In addition, as blood-based biomarkers, beta-site amyloid precursor protein cleaving enzyme (BACE)1 in incipient dementias and neurofilament light (NF-L) as a general marker for neurodegeneration are currently widely studied [8]. The gene discussed is NEFL; the disease is dementia.